Yasunori Iwashima

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 300 citations

Non-pharmacological Intervention, Diabetes Management, Cardiovascular Disease +9

Advanced Glycation End Products-Induced Gene Expression of Scavenger Receptors in Cultured Human Monocyte-Derived Macrophages

Yasunori Iwashima, Masaaki Eto, Akira Hata et al. · Biochemical and Biophysical Research Communications · 2000 · 100 citations

Inflammation, Cytokine, Immunology +9

Elevation of Plasma Thrombomodulin Level in Diabetic Patients With Early Diabetic Nephropathy

Yasunori Iwashima, Takao Sato, Kiyoshi Watanabe et al. · Diabetes · 1990 · 98 citations

Immunology, Early Diabetic Nephropathy, Diabetic Patients +21

Expression of Calcium Channel mRNAs in Rat Pancreatic Islets and Downregulation After Glucose Infusion

Yasunori Iwashima, William Pugh, Alex M. DePaoli et al. · Diabetes · 1993 · 96 citations

Apolipoprotein E Polymorphism and Hyperlipemia in Type II Diabetics

Masashi Eto, K. Watanabe, Yasunori Iwashima et al. · Diabetes · 1986 · 70 citations

Obesity, Metabolic Syndrome, Apolipoprotein E Polymorphism +13